Back

Early realworld use of acoramidis insights from the german starTTR cohort

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pharmacotherapy (2) Pharmacotherapy Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Caroline Morbach

University Hospital Wuerzburg, Wuerzburg (Germany)

8 More presentations in this session

Presentation thumbnail
Effect of SGLT-2 inhibitors on the incidence of right ventricular dysfunction in patients with chronic heart failure
Doctor G. Severini (Catanzaro, IT)
Abstract Slides
Presentation thumbnail
Tafamidis for the treatment of wild-type transthyretin cardiac amyloidosis: insights from a regional hospital experience
Doctor A. Martins (Leiria, PT)
Abstract Slides
Presentation thumbnail
Transitions in heart failure therapy prior to acoramidis use in transthyretin cardiomyopathy: real world insights from the german starttr cohort
Doctor C. Morbach (Wuerzburg, DE)
Abstract Slides
Presentation thumbnail
Digoxin use and heart failure hospitalization in patients with heart failure with preserved ejection fraction: a real-world retrospective analysis
Associate Professor B. MURAT (Eskisehir, TR)
Abstract Slides
Presentation thumbnail
Effect of vericiguat on echodynamics and myocardial remodeling in patients with heart failure with reduced ejection fraction
Doctor C. Carbonaro (Turin, IT)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - pharmacotherapy (2)

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Presentation
Audience Q&A
thumbnail
Congress Presentation
Treating heart failure in adult congenital heart disease: A-Z

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources